About
Decentralized Rapid RNA Diagnostic Solutions
NAOR is a platform for rapid RNA diagnosis of COVID-19 and other pathogens. The company uses a one-step nucleic acid amplification method to multiply specific sequences of RNA, resulting in extremely high sensitivity and specificity. The technology enables high-volume lab-grade results in field settings such as airports, schools, and workplaces. The tests can also be conducted at home.
Originally developed at the Technion, the technology combines biochemistry, electronics, and artificial intelligence. The original clinical study (with results from Rambam Medical Center) was one of the first to use rapid RNA testing of the virus. The company has since gathered significant data from around the world and further developed the technology. Its platform is now available in select markets worldwide.
NAOR is developed by Rapid Diagnostic System Ltd.
Identity
| Name | NAOR |
|---|---|
| Slug | rapid-diagnostic-systems-ltd-naor |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4MWTptQLDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Mar 2024 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Haifa |
| HQ address | Haifa, Israel |
Classifications
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}